Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:SSNC News 8 July 2025

June–July 2025 Update: Workflow Automation & RPA Industry Report

June–July 2025 Update: Workflow Automation & RPA Industry Report

Gartner’s 2025 Magic Quadrant for RPA, released in late June 2025, again names Automation Anywhere, Microsoft, SS&C Blue Prism, and UiPath as Leaders for the seventh consecutive year. Gartner warned about ‘agent washing’ and projected that by 2027 more than 40% of agentic AI projects could be canceled due to unclear ROI. UiPath announced a mid-June 2025 launch of a next-generation Agentic Automation Platform in Australia, unifying AI agents, RPA bots, and human workflows and introducing UiPath Maestro as the orchestration layer with a Google Cloud Agent-to-Agent protocol for secure AI-agent communication. UiPath reported thousands of AI agents created and
8 July 2025
·····

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop